BERNARDINELLO, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.251
AS - Asia 237
EU - Europa 210
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.699
Nazione #
US - Stati Uniti d'America 1.251
CN - Cina 149
SG - Singapore 68
DE - Germania 63
SE - Svezia 35
FI - Finlandia 34
IT - Italia 33
UA - Ucraina 19
VN - Vietnam 15
GB - Regno Unito 10
FR - Francia 8
IE - Irlanda 5
IN - India 4
DK - Danimarca 1
EU - Europa 1
HK - Hong Kong 1
NL - Olanda 1
SI - Slovenia 1
Totale 1.699
Città #
Chandler 136
Woodbridge 125
Fairfield 124
Jacksonville 106
Houston 81
Wilmington 65
Ashburn 61
Ann Arbor 60
Cambridge 59
Singapore 54
Santa Clara 47
Seattle 43
Boardman 37
Princeton 37
Des Moines 26
Beijing 23
Guangzhou 22
Nanjing 17
Dong Ket 15
Medford 14
San Diego 12
Hefei 11
Helsinki 11
Nanchang 11
Redwood City 11
Dallas 9
Dearborn 9
Roxbury 8
New York 7
Milan 6
Shenyang 6
Cesa 5
Dublin 5
Fremont 5
Jiaxing 5
Changsha 4
Hebei 4
Jinan 4
Detroit 3
Kunming 3
London 3
Norwalk 3
Padova 3
Tianjin 3
Legnaro 2
Nürnberg 2
Oggiono 2
Pune 2
Rome 2
Saronno 2
Shanghai 2
Atlanta 1
Baotou 1
Chongqing 1
Hong Kong 1
Hounslow 1
Kharkiv 1
L'aquila 1
Lanzhou 1
Leawood 1
Los Angeles 1
Ningbo 1
Ogden 1
Rockville 1
Sankt Augustin 1
Savannah 1
Simi Valley 1
Turin 1
Vedbæk 1
Wuhan 1
Zhengzhou 1
Totale 1.337
Nome #
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. 128
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 113
Kinetic of virological response during PEG-IFNs in chronic hepatitis C. 112
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 107
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 106
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 100
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 95
Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage 93
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 86
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C 82
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 78
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 65
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 62
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 58
SCCA EXPRESSION IN PBMCs IN PATIENTS WITH CHRONIC HEPATITIS C 57
Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group. 54
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 53
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 52
Terapia con Peg-interferone e ribavirina nell'epatite cronica C: costo-efficacia e farmacoutilizzazione nella comune pratica clinica 47
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 44
The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C 42
CLINICAL SIGNIFICANCE OF SERUM AND LIVER TISSUE SCCA IN CHRONIC HEPATITIS 34
Studio epidemiologico e prospettico delle epatopatie croniche: un progetto pilota nelle province di Padova e Venezia 31
Totale 1.699
Categoria #
all - tutte 6.354
article - articoli 4.790
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 288
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020211 0 0 0 0 0 27 43 38 27 45 16 15
2020/2021198 5 16 4 14 13 27 5 18 39 14 18 25
2021/2022240 1 33 31 19 7 24 10 21 15 2 31 46
2022/2023296 44 35 10 25 57 51 0 16 36 1 18 3
2023/202490 5 16 10 6 6 10 4 2 4 3 9 15
2024/2025188 1 47 18 32 72 18 0 0 0 0 0 0
Totale 1.699